quinoxalines has been researched along with Carotid Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, D; Li, HC; Xu, YL; Zhang, GY; Zhang, QG | 1 |
| Bogaert, L; Bond, A; Ebinger, G; Hicks, CA; Lodge, D; Michotte, Y; O'Neill, MJ; Ornstein, PL; Ward, MA | 1 |
2 other study(ies) available for quinoxalines and Carotid Stenosis
| Article | Year |
|---|---|
NMDA receptor/L-VGCC-dependent expression and AMPA/KA receptor-dependent activation of c-Jun induced by cerebral ischemia in rat hippocampus.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Carotid Stenosis; Enzyme Activation; Hippocampus; Ischemic Attack, Transient; JNK Mitogen-Activated Protein Kinases; Ketamine; Male; Nifedipine; Phosphorylation; Protein Binding; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Reperfusion; Transcription Factor AP-1 | 2006 |
LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.
Topics: Animals; Brain Ischemia; Carotid Stenosis; Cell Death; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Gerbillinae; Hippocampus; In Situ Nick-End Labeling; Isoquinolines; Male; Microdialysis; Motor Activity; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Kainic Acid; Tetrazoles | 2000 |